| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/2003 | CA2119463C Glial cell line-derived neutrophic factor |
| 09/16/2003 | CA2088676C High viscosity bacteria, bacterial compositions, and methods |
| 09/16/2003 | CA2054590C Novel cyclosporins |
| 09/15/2003 | CA2422480A1 Promoters for molecular farming and/or early detection of transgenic plants |
| 09/12/2003 | WO2003075014A2 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 |
| 09/12/2003 | WO2003074992A2 Phosphorylated proteins and uses related thereto |
| 09/12/2003 | WO2003074736A1 Diagnostics and remedies for malignant brain tumor |
| 09/12/2003 | WO2003074726A2 Immune response associated proteins |
| 09/12/2003 | WO2003074725A2 MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE |
| 09/12/2003 | WO2003074722A2 Microarrays of cellulose binding chimeric proteins and methods of use thereof |
| 09/12/2003 | WO2003074712A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof |
| 09/12/2003 | WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 09/12/2003 | WO2003074705A1 Proteins capable of binding to environmental hormones and process for producing the same |
| 09/12/2003 | WO2003074704A1 Proteins capable of binding to female sex hormones and process for producing the same |
| 09/12/2003 | WO2003074703A1 Novel transcriptional factor, dna thereof and use of the same |
| 09/12/2003 | WO2003074702A1 Novel protein and dna thereof |
| 09/12/2003 | WO2003074699A1 Process for producing physiologically active protein using genetically modified silkworm |
| 09/12/2003 | WO2003074694A1 Adipocyte differentiation-associated genes and proteins |
| 09/12/2003 | WO2003074692A2 Specific gene expression in colonic cancer cell lines |
| 09/12/2003 | WO2003074685A2 Il-10 gene transfer to peripheral blood mononuclear cells |
| 09/12/2003 | WO2003074677A2 MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
| 09/12/2003 | WO2003074675A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/12/2003 | WO2003074673A2 Lgals as modifiers of the chk pathway and methods of use |
| 09/12/2003 | WO2003074672A2 Crebpas as modifiers of cell death pathways and methods of use |
| 09/12/2003 | WO2003074667A2 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells |
| 09/12/2003 | WO2003074664A2 Cloning and characterization of slc26a7 and slc26a9 anion exchangers |
| 09/12/2003 | WO2003074663A2 MP21s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 09/12/2003 | WO2003074661A2 Cloning and characterization of a novel bk channel isoform highly expressed in glioma cells |
| 09/12/2003 | WO2003074657A2 Cold shock inducible expression and production of heterologous polypeptides |
| 09/12/2003 | WO2003074656A2 Rank-ligand-induced sodium/proton antiporter polypeptides |
| 09/12/2003 | WO2003074653A2 Nucleic acid molecules encoding proteins essential for plant growth and development and uses thereof |
| 09/12/2003 | WO2003074565A2 Peptides for use in antitumor immunotherapy |
| 09/12/2003 | WO2003074564A1 Novel hemepeptide |
| 09/12/2003 | WO2003074562A2 Vanilloid receptor (trpv) fusion proteins |
| 09/12/2003 | WO2003074560A2 Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto |
| 09/12/2003 | WO2003074559A1 Falp proteins |
| 09/12/2003 | WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom |
| 09/12/2003 | WO2003074557A1 Novel b-cell malignancy-associated protein |
| 09/12/2003 | WO2003074556A1 Tumor tag and the use thereof |
| 09/12/2003 | WO2003074555A2 Synthetic peptides from c. difficile |
| 09/12/2003 | WO2003074554A2 Apoptogenic-bacteriocins combining broad spectrum antibiotic and selective anti-tumoral activities, and compositions and uses thereof |
| 09/12/2003 | WO2003074553A2 Expec-specific proteins, genes encoding them and uses thereof |
| 09/12/2003 | WO2003074552A1 An infectious bursal disease virus variant |
| 09/12/2003 | WO2003074549A2 Assay for anti-ingap antibodies |
| 09/12/2003 | WO2003074547A2 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor |
| 09/12/2003 | WO2003074546A2 Streptavidin-binding peptide |
| 09/12/2003 | WO2003074543A1 Anti-protozoal vaccine |
| 09/12/2003 | WO2003074128A2 Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds |
| 09/12/2003 | WO2003074081A1 SPECIFIC ANTIBODIES TO AMYLOID β PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF |
| 09/12/2003 | WO2003074077A1 Purification of red blood cells by separation and diafiltration |
| 09/12/2003 | WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 09/12/2003 | WO2003074007A2 Modulators of leukocyte activation, compositions, and methods of use |
| 09/12/2003 | WO2003074005A2 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 09/12/2003 | WO2003074004A2 Method of producing antigens |
| 09/12/2003 | WO2003074001A2 Methods for designing specific inhibitors for pin1 proline isomerase and pin1-related molecules |
| 09/12/2003 | WO2003073984A2 Tat as an immunogen |
| 09/12/2003 | WO2003073841A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors |
| 09/12/2003 | WO2003073836A2 A stress-responsive promoter from maize |
| 09/12/2003 | WO2003066674A3 Viral cd30 polypeptide |
| 09/12/2003 | WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use |
| 09/12/2003 | WO2003048371A3 Dna vaccine |
| 09/12/2003 | WO2003048364A3 Ovomucoid promoter and methods of use |
| 09/12/2003 | WO2003047525A3 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye |
| 09/12/2003 | WO2003046133A3 Regulatory nucleic acid assay for diagnostic and library screens |
| 09/12/2003 | WO2003044160A3 Novel molecules of the card related protein family and uses thereof |
| 09/12/2003 | WO2003038034A3 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary |
| 09/12/2003 | WO2003035884A3 Transient immortalization |
| 09/12/2003 | WO2003026401A3 Kv3.3b POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO |
| 09/12/2003 | WO2003014365A9 Plant glycogenin homologs and use thereof in starch modification |
| 09/12/2003 | WO2003011893A3 Immunologically significant herpes simplex virus antigens and methods for using same |
| 09/12/2003 | WO2003007794A3 Invasion complex and methods of targeting |
| 09/12/2003 | WO2003001877A3 Methods for the diagnosis and treatment of cardiac tissue rejection |
| 09/12/2003 | WO2003000734A3 Ion channel modulators |
| 09/12/2003 | WO2002099076A3 Sugar and lipid metabolism regulators in plants ii |
| 09/12/2003 | WO2002090500A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 09/12/2003 | WO2002088314A3 Ovary-specific genes and proteins |
| 09/12/2003 | WO2002086066A3 Novel expansin polynucleotides, related polypeptides and methods of use |
| 09/12/2003 | WO2002083077A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 09/12/2003 | WO2002075507A3 Anti-bacterial vaccine compositions |
| 09/12/2003 | WO2002074960A3 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof |
| 09/12/2003 | WO2002072830A3 Proteins associated with cell growth, differentiation, and death |
| 09/12/2003 | WO2002068682A3 Method for identifying biologically active structures of microbial pathogens |
| 09/12/2003 | WO2002062205A3 Methods for diagnosing and treating heart disease |
| 09/12/2003 | WO2002059263A9 Transgenic animals comprising a humanized immune system |
| 09/12/2003 | WO2002058727A3 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine |
| 09/12/2003 | WO2002057311A9 Sphingosine 1-phosphate receptor gene, sppr |
| 09/12/2003 | WO2002054080A3 Proteins, genes and their use for diagnosis and treatment of vascular response |
| 09/12/2003 | WO2002053739A8 Neuropilin homolog zcub5 |
| 09/12/2003 | WO2002052011A3 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1 |
| 09/12/2003 | WO2002048370A3 Compositions and methods relating to colon specific genes and proteins |
| 09/12/2003 | WO2002048343A3 Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions |
| 09/12/2003 | WO2002046391A3 Transgenic mice containing nori gene disruptions |
| 09/12/2003 | WO2002044390A3 Floral development genes |
| 09/12/2003 | WO2002044204A3 Cell-free assembly of lentiviral capsids |
| 09/12/2003 | WO2002042461A3 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/12/2003 | WO2002040504A8 Sol-fusin: use of gp64-6his to catalyze membrane fusion |
| 09/12/2003 | WO2002040059A3 Methods and compositions for inducing cell-mediated immune responses |
| 09/12/2003 | WO2002036616A3 Compositions and methods relating to breast specific genes and proteins |
| 09/12/2003 | WO2002032961A8 Novel polypeptides and nucleic acids encoding same |
| 09/12/2003 | WO2002018572A3 Membrane penetrating peptides and uses thereof |